Secondary immune thrombocytopenia supposedly attributable to COVID-19 vaccination.

Omar Fueyo-RodriguezBenjamin Valente-AcostaRodolfo Jimenez-SotoYvette Neme-YunesSergio Ignacio Inclán-AlarcónRoxana Trejo-GonzalezMiguel Ángel García-Salcido

Published in: BMJ case reports (2021)

Immune thrombocytopenia (ITP) has been widely reported as a complication of SARS-CoV-2 infection, but to our knowledge, there have been no reports on the association of the COVID-19 vaccine with thrombocytopenia. Here, we report a case of secondary ITP in a patient who was recently immunised with the messenger RNA COVID-19 vaccine BNT162b2 (Pfizer-BioNTech).

Keyphrases

coronavirus disease
sars cov
respiratory syndrome coronavirus
healthcare
case report
adverse drug
electronic health record
drug induced